AnaptysBio, Inc. is a clinical stage biotechnology company. engages in the development of antibody product candidates. Its products pipeline include ANB030, ANB030, and Imsidolimab. It also offers SHM platform that replicate the natural process of somatic hypermutation embedded within the human immune system to rapidly develop a diverse range of therapeutic-grade antibodies in vitro. The company was founded by Andrew B. Cubitt, William J. Boyle, Kevin J. Kinsella, and Nicholas B. Lydon in November 2005 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is the 52-week high for AnaptysBio Inc - When Issued - April 2026?
52 week high is the highest price of a stock in the past 52 weeks, or one year. AnaptysBio Inc - When Issued - April 2026 52 week high is $45.52 as of April 08, 2026.
What is the 52-week low for AnaptysBio Inc - When Issued - April 2026?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. AnaptysBio Inc - When Issued - April 2026 52 week low is $43.44 as of April 08, 2026.
What is AnaptysBio Inc - When Issued - April 2026 stock price today?
AnaptysBio Inc - When Issued - April 2026 stock price today is $43.44.
What was AnaptysBio Inc - When Issued - April 2026 stock price yesterday?
AnaptysBio Inc - When Issued - April 2026 stock price yesterday was $45.52.
What is the 50-day moving average of AnaptysBio Inc - When Issued - April 2026?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. AnaptysBio Inc - When Issued - April 2026 50-day moving average is $44.48.